Detailed information for compound 291055

Basic information

Technical information
  • TDR Targets ID: 291055
  • Name: N-(6-chloro-2-methyl-1H-benzimidazol-4-yl)ace tamide
  • MW: 223.659 | Formula: C10H10ClN3O
  • H donors: 2 H acceptors: 2 LogP: 1.69 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)Nc1cc(Cl)cc2c1nc([nH]2)C
  • InChi: 1S/C10H10ClN3O/c1-5-12-8-3-7(11)4-9(10(8)13-5)14-6(2)15/h3-4H,1-2H3,(H,12,13)(H,14,15)
  • InChiKey: GZONQVYVJJXHMO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-(6-chloro-2-methyl-1H-benzimidazol-4-yl)ethanamide
  • AIDS-157367
  • AIDS157367
  • N-(6-Chloro-2-methyl-1H-benzimidazol-4-yl)acetamide hydrochloride
  • NSC638675 (HYDROCHLORIDE SALT)

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Treponema pallidum NADH oxidase 0.0021 0 0.5
Trichomonas vaginalis Importin beta-1 subunit, putative 0.0026 0.0047 0.0047
Schistosoma mansoni ran 0.0024 0.0023 0.0073
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0021 0 0.5
Trichomonas vaginalis Importin beta-1 subunit, putative 0.0026 0.0047 0.0047
Trypanosoma cruzi importin beta-1 subunit, putative 0.0026 0.0047 0.118
Trichomonas vaginalis FMN-dependent NADH-azoreductase, putative 0.0123 0.1008 0.1008
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Echinococcus multilocularis thioredoxin glutathione reductase 0.0062 0.04 0.1249
Loa Loa (eye worm) nucleolar RNA-associated protein alpha 0.0343 0.3203 1
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0307 0.284 0.284
Echinococcus multilocularis snurportin 1 0.0343 0.3203 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Brugia malayi Importin beta-1 subunit 0.0032 0.0108 0.1544
Schistosoma mansoni hypothetical protein 0.0343 0.3203 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0021 0 0.5
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Loa Loa (eye worm) glutathione reductase 0.0062 0.04 0.1185
Trypanosoma cruzi GTP-binding nuclear protein rtb2, putative 0.0024 0.0023 0.0582
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0021 0 0.5
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Leishmania major importin beta-1 subunit, putative 0.0026 0.0047 0.118
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Plasmodium vivax importin-beta 2, putative 0.0032 0.0108 0.2693
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0021 0 0.5
Trypanosoma brucei importin beta-1 subunit, putative 0.0032 0.0108 0.2693
Plasmodium vivax glutathione reductase, putative 0.0062 0.04 1
Trypanosoma brucei GTP-binding nuclear protein rtb2, putative 0.0024 0.0023 0.0582
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0062 0.04 1
Giardia lamblia NADPH oxidoreductase, putative 0.0307 0.284 1
Schistosoma mansoni ran 0.0024 0.0023 0.0073
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trypanosoma cruzi trypanothione reductase, putative 0.0062 0.04 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Echinococcus multilocularis importin subunit beta 1 0.0032 0.0108 0.0336
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Plasmodium vivax GTP-binding nuclear protein RAN/TC4, putative 0.0024 0.0023 0.0582
Plasmodium falciparum glutathione reductase 0.0062 0.04 1
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trichomonas vaginalis importin beta-1, putative 0.0026 0.0047 0.0047
Giardia lamblia NADPH oxidoreductase, putative 0.0307 0.284 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Toxoplasma gondii thioredoxin reductase 0.0062 0.04 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis conserved hypothetical protein 0.0184 0.162 0.162
Echinococcus granulosus snurportin 1 0.0343 0.3203 1
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Plasmodium falciparum GTP-binding nuclear protein RAN/TC4 0.0024 0.0023 0.0582
Loa Loa (eye worm) thioredoxin reductase 0.0062 0.04 0.1185
Trichomonas vaginalis ran, putative 0.0024 0.0023 0.0023
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Echinococcus granulosus thioredoxin glutathione reductase 0.0062 0.04 0.1249
Giardia lamblia NADPH oxidoreductase, putative 0.0307 0.284 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Echinococcus multilocularis GTP binding nuclear protein Ran 0.0024 0.0023 0.0073
Trypanosoma brucei importin beta-1 subunit, putative 0.0032 0.0108 0.2693
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0021 0 0.5
Brugia malayi glutathione reductase 0.0062 0.04 0.5736
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0307 0.284 0.284
Leishmania major GTP-binding protein, putative 0.0024 0.0023 0.0582
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Entamoeba histolytica hypothetical protein 0.0026 0.0047 0.0243
Brugia malayi RNA, U transporter 1 0.0091 0.0697 1
Echinococcus granulosus GTP binding nuclear protein Ran 0.0024 0.0023 0.0073
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trypanosoma cruzi GTP-binding nuclear protein rtb2, putative 0.0024 0.0023 0.0582
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0021 0 0.5
Entamoeba histolytica iron-sulfur flavoprotein, putative 0.0123 0.1008 1
Echinococcus granulosus importin subunit beta 1 0.0032 0.0108 0.0336
Trypanosoma brucei trypanothione reductase 0.0062 0.04 1
Schistosoma mansoni importin beta-1 0.0032 0.0108 0.0336
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Plasmodium falciparum thioredoxin reductase 0.0062 0.04 1
Plasmodium falciparum importin beta, putative 0.0032 0.0108 0.2693
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.0307 0.284 0.284
Giardia lamblia GTP-binding nuclear protein RAN/TC4 0.0024 0.0023 0.0082
Toxoplasma gondii HEAT repeat-containing protein 0.0032 0.0108 0.2693
Loa Loa (eye worm) hypothetical protein 0.0032 0.0108 0.0266
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Entamoeba histolytica hypothetical protein 0.0123 0.1008 1
Entamoeba histolytica modulator of drug activity B homolog, putative 0.0123 0.1008 1
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Brugia malayi GTP-binding nuclear protein RAN/TC4 0.0024 0.0023 0.0334
Leishmania major trypanothione reductase 0.0062 0.04 1
Trichomonas vaginalis NAD(P)H dehydrogenase, putative 0.1027 1 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Trichomonas vaginalis conserved hypothetical protein 0.0123 0.1008 0.1008
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Toxoplasma gondii GTP-binding nuclear protein ran/tc4 0.0024 0.0023 0.0582
Plasmodium vivax thioredoxin reductase, putative 0.0062 0.04 1
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008
Brugia malayi Thioredoxin reductase 0.0062 0.04 0.5736
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0021 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0307 0.284 0.284
Trichomonas vaginalis modulator of drug activity B, putative 0.0123 0.1008 0.1008

Activities

Activity type Activity value Assay description Source Reference
IC50 (ADMET) = 3.51 Inhibitory potency to aminopyrine N-demethylase activity (P450) in hepatic microsomes from phenobarbitone-induced rats. ChEMBL. 7120277
logP (ADMET) = 1.27 Partition coefficient (logP) ChEMBL. 7120277
pI50 (ADMET) = 3.51 Inhibitory potency to aminopyrine N-demethylase activity (P450) in hepatic microsomes from phenobarbitone-induced rats. ChEMBL. 7120277

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.